Search Results for: diet
Why do 5-HIAA urine tests sometimes come back high and other times low after carcinoid tumors have been removed?
The urine 5-HIAA test for carcinoid is crude and can be strongly influenced by special diet and drugs. The patient must be on a special diet before and during the urine collection. Even then the test can miss up to 50% of the cases. It should not be relied on …
READ MOREWhat about fat — if red meat is tolerated is it okay to eat?
The only reason for carcinoid patients to eat a low fat diet would be to reduce steatorrhea (fat-containing diarrhea) if they have malabsorption due to short bowel syndrome or as a side effect of Sandostatin. If fat malabsorption is present or even suggested,…
READ MOREUN ANÁLISIS DEL CÁNCER NEUROENDOCRINO
Este documento se preparó para promover los objetivos educativos de La Fundación del Cáncer Carcinoide (Carcinoid Cancer Foundation) e informarle sobre la existencia y las características del cáncer neuroendocrino. Mientras la información contenida…
READ MOREA Review of Neuroendocrine Cancer
This document was prepared in order to further the Carcinoid Cancer Foundation’s educational goals and inform you about the existence and characteristics of neuroendocrine cancer. While the information contained herein represents up-to-date…
READ MOREWhy do 5-HIAA urine tests sometimes come back high and other times low after carcinoid tumors have been removed?
The urine 5-HIAA test for carcinoid is crude and can be strongly influenced by special diet and drugs. The patient must be on a special diet before and during the urine collection. Even then the test can miss up to 50% of the cases. It should not be relied on …
READ MORE
New Jersey Carcinoid/Neuroendocrine Cancer Conference in October, Registration Closing Soon
Two of the country’s leading carcinoid and neuroendocrine cancer specialists, a cardiologist with expertise in carcinoid heart disease, a registered dietitian who works regularly with the NET community, and a nurse practitioner with extensive…
READ MORE
Denied: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment
The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught…
READ MORE
DENIED: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment
The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught…
READ MORE
Josh Mailman’s Patient Perspective on Integrative Oncology
“A Patient’s Perspective on Integrative Oncology: Getting Past the ‘War,’ Living with and Beyond Cancer” by Josh Mailman has been published in the November 2014 issue of the Journal of the National Cancer Institute Monographs focused on Integrative…
READ MOREJosh Mailman’s Patient Perspective on Integrative Oncology Published
“A Patient’s Perspective on Integrative Oncology: Getting Past the ‘War,’ Living with and Beyond Cancer” by Josh Mailman has been published in the November 2014 issue of the Journal of the National Cancer Institute Monographs focused on Integrative…
READ MORE
